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The present study aimed to investigate the protective effects of silymarin (SMN), an antioxidant, on 
methotrexate (MTX)-induced damage in rat testes. Thirty-two Wistar albino rats were divided into four 
groups (n = 8): control, MTX (20 mg/kg, i.p. on days 1 and 5), SMN (200 mg/kg, orally), and MTX 
+ SMN (20 mg/kg, i.p. on days 1 and 5 and SMN 200 mg/kg orally) groups. At the end of the 6-week 
trial period, histopathological, immunohistochemical, biochemical, and spermatological analyses were 
performed on testes tissues. Histopathologically, MTX-induced damage, including depletion of germ 
cell and loos of spermatozoa, was significantly improved with SMN treatment. Immunohistochemically, 
the immunoreactivity of glutathione peroxidase 1 (GPx1) and manganese superoxide dismutase 2 
(SOD2) were detected more intensely in the MTX + SMN group than in the MTX group. Biochemical 
examinations revealed that SMN supplementation decreased the lipid peroxidation and increased 
enzymatic antioxidants in the SMN-treated rats. Spermatologically, significant differences were found 
in the density, motility, dead-to-live sperm ratio, and abnormal sperm rate in the MTX + SMN group 
compared to the MTX group. In conclusion, SMN seems to have protective effects as an antioxidant 
against MTX-induced damage in rat testes.
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INTRODUCTION
Methotrexate (MTX) is a folic acid antagonist 
that has anti-neoplastic characteristics (Thomson et al., 
2012). It has been used to treat rheumatic diseases since 
the 1950s (Gogus, 2001) and has been used to treat acute 
lymphoblastic leukemia; lymphoma; osteosarcoma; and 
breast, head and neck cancers; as well as non-malignant 
diseases like psoriasis and rheumatic arthritis. MTX has 
toxic effects, particularly on rapidly proliferating cells, 
such as gastrointestinal epithelial and bone marrow 
cells (Sargin et al., 2009), and studies have reported 
that MTX causes damage in certain organs, such as the 
kidneys (Sargin et al., 2009), liver (Asci, Ozer, 2011), and 
intestines (Vardi et al., 2008).
Testicular damage is the most important potential 
side effect of MTX (Yuluğ et al., 2013) and can lead 
to infertility (Moris et al., 1993). Previous studies have 
reported damage in the seminiferous tubules of the testes, 
decreased sperm count, and sperm DNA damage after 
MTX administration (Padmanabhan et al., 2009; Yuluğ et 
al., 2013). Additionally, MTX causes defective oogenesis 
and spermatogenesis (Vardi et al., 2009). Oxidative stress 
has an important effect in the pathogenesis of MTX-
induced testicular damage (Armagan et al., 2008). It leads 
to damage to the structure of the testes and germ cells 
(Atessahin, Şahna, Türk, 2006). Therefore, it is important 
to reduce cellular oxidative stress in patients receiving 
MTX (Vardi et al., 2009).
In several studies, polyphenolic compounds have 
shown to be potential antioxidants useful for the treatment 
and prevention of oxidative stress (Uyar, Yener, Dogan, 
2016; Yaman, Yener, Celik, 2016). Antioxidant agents are 
used to minimize the adverse effects of anticancer drugs 
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on the testicles (Muslimovic et al., 2009; Padmanabhan et 
al., 2009). These agents deactivate free radicals by sending 
electrons to attack them, and antioxidants offer protection 
from free radicals and lipid peroxidation (Valavanidis et 
al., 2006) by inhibiting or delaying cellular damage with 
their free radical-scavenging effect (Halliwell, 1995). Prior 
studies conducted to identify ways in which to prevent the 
testicular damage caused by MTX have reported that the 
damage is largely prevented by antioxidants like vitamin 
E, L-carnitine (Bükücü, 2013), vitamin C (Sayilmaz, 
2015), and caffeic acid phenethyl ester (Armagan et al., 
2008).
Silymarin (SMN) is a natural polyphenolic 
compound isolated from the seeds of Silybum marianum 
(milk thistle). SMN can inhibit both free radicals and 
reactive oxygen species (ROS). It reacts with the latter and 
converts them into compounds with decreased reactivity 
and toxicity. It also potentiates the effects of physiological 
antioxidants, such as glutathione and superoxide dismutase 
(SOD) (Nencini, Giorgi, Micheli, 2007; Moshtaghion et 
al., 2013). Previous studies suggest that SMN could 
protect tissues against toxicity from the most commonly 
used anticancer agents (Rašković et al., 2011).
The present study aimed to investigate the 
antioxidant properties and protective role of SMN against 
MTX-induced testicular damage. We also demonstrated 
the immunolocalization of GPx1 and SOD2 in testicular 
tissue. 
MATERIAL AND METHODS
Chemicals
The chemicals used in this study were supplied 
by Sigma Chemical Co. (St. Louis, MO, USA). Kits for 
antioxidant enzyme analysis were provided by Randox 
Laboratories Ltd. SMN powder was purchased from 
Sigma (S0292, USA). MTX (Koçak Farma, Tekirdağ, 
Turkey) was purchased from a local pharmacy.
Animals
Thirty two Wistar albino male rats aged 4–6 
months and weighing 200–300 g were provided by the 
Experimental Animal Research Center, Dicle University. 
The animals were housed at 20 ± 2 °C under daily light/
dark cycle. They were kept in stainless cages and fed 
a wheat and soybean-meal-based diet. Water and feed 
were provided ad libitum. Ethics regulations were 
followed in accordance with the national and institutional 
guidelines for the protection of animal welfare during 
the experiments. This study was approved by the ethics 
committee of Dicle University (Protocol number: 
2015/7).
Experimental model
The rats were randomly divided into four groups 
(n = 8).
Control group (C): Rats in this group received 0.9% 
NaCl (1 ml/kg, orally).Those in the MTX group received 
MTX (20 mg/kg, intraperitoneally [i.p.]) on days 1 and 5, 
while the rats in the MTX + SMN group received MTX 
(20 mg/kg, i.p.) on days 1 and 5 and SMN (200 mg/kg, 
orally) for 6 weeks. Lastly, the rats in the SMN group 
received only SMN (200 mg/kg, orally) for 6 weeks.
Histopathological examination
At the end of the experiments, the body weight of 
all rats was recorded, and they were then administered 
50 mg/kg ketamine and 10 mg/kg xylazine hydrochloride 
i.p. anesthesia. Necropsy was performed on all animals, 
and macroscopic changes in the testicles were recorded. 
Tissue samples were collected from the testicles and 
fixed in Boin’s solution. After routine tissue follow-up, 
the samples were embedded in paraffin blocks; 4-μm 
sections were taken using a microtome (Leica RM 2135), 
stained with hematoxylin-eosin, and examined under a 
light microscope (Nikon 80i-DS-RI2). Histopathological 
findings were graded as mild (*), medium (**), and severe 
(***).
Immunohistochemical staining
Immunohistochemical (IHC) examination was 
performed to investigate GPx1 and SOD2 expression. The 
streptavidin-peroxidase method (ABC) was used to stain 
the sections. Commercial antibodies were visualized on 
5-μm-thick paraffin sections using an indirect streptavidin/
biotin immunoperoxidase kit (Histostain-Plus Bulk Kit; 
Zymed, South San Francisco, CA, USA). Tissue sections 
were incubated with the GPx1 (abcam-ab22604) (1:400) 
and SOD2 (abcam-ab13533) (1:200) primary antibodies 
overnight at 4 °C. Finally, to visualize the reactions, the 
sections were reacted for 5–15 min with diaminobenzidine 
(DAB). After the DAB reactions developed, the sections 
were counterstained with hematoxylin. We used negative 
controls to verify the staining; these slides were reacted 
with PBS instead of primer antibodies. All slides were 
examined and photographed using a light microscope 
(Nikon 80i-DS-RI2).
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Quantitative analysis
Immunohistochemical staining was evaluated 
semiquantitatively using a double grading system, using 
a so-called quick score (Q), which comprised an intensity 
score (I) and proportional score (P). The I score reflect the 
intensity of positive staining in cell nuclei and cytoplasm, 
while the P score reflects the percentage of cell nuclei and 
cytoplasms with positive staining (Sagsöz, Saruhan, 2011). 
In this method, the intensity of staining was evaluated 
as follows: 0, negative staining; 1, weak staining; 2, 
intermediate staining; 3, strong staining. To evaluate the 
P score, the expression of GPx-1 and SOD2 in the testes 
was examined microscopically at 400× magnification. 
Five randomly selected areas including at least 100 cells 
were evaluated per section. The proportions of stained 
nuclei and cytoplasm of cells were recorded as follows: 
0%, 0; approximately 1%, 1; 1 – 10%, 2; 11 – 33%, 3; 34 
– 66%, 4; and 67 – 100%, 5. The I score was then added 
to the P score, which yielded the Q score, which ranged 
from 0 to 8.
Biochemical analysis
After the experimental treatment, blood and post-
necropsy testicular tissue samples were withdrawn from 
the rats for biochemical analyses. The testicle samples 
were studied for malondialdehyde (MDA), GPx catalase 
(CAT), and SOD. The level of MDA in the tissues was 
determined using the method described by Jain et al. 
(1989) based on thiobarbituric acid reactivity.
Spermatological examination
In studies on rat sperm, density is usually determined 
by counting epididymal or testicular sperms. Epididymal 
sperm can be counted by counting the sperms in the caput, 
corpus, cauda, or whole epididymis (Amann, Lambiase, 
1969). In general, researchers most often use the method 
of counting epididymal sperm (Robb, Amann, Killian, 
1978). In the present study, the sperm density in the caudal 
epididymis was examined after sperms were collected 
via puncture from the according to the method of Robb 
et al. (1978), immediately after the rats were dissected. 
Spermatological tests were also conducted using classic 
sperm testing methods.
Statistical analyses
All data were expressed as mean ± standard deviation 
(SD). The statistical analyses were made using Minitab 13 
for windows packet program. One way ANOVA statistical 
test was used to determine the differences between means 
of the treatments and the control group accepting the 
significance level at p ≤ 0.05. The differences among the 
pathological changes were also determined by chi-square 
test.
RESULTS AND DISCUSSION
Histopathological findings
Table I shows the histopathological lesions, number 
of affected rats, and the severity of the alterations. No 
gross lesions were observed in the testis structures of 
rats in the control, SMN, and MTX + SMN groups. 
However, the testicles of the rats in the MTX group 
showed congested darkcolored areas at the serosa. 
Microscopically, the testicular sections from the control 
(Figure 1A) and SMN (Figure 1B) groups had normal 
histological appearances. In the MTX group, germ cells 
were dissociated from the basal membrane, and several 
immature germinal cell accumulations were observed 
in the lumen of seminiferous tubules. A widespread 
loss of spermatozoa was also observed in the tubular 
lumens. Moreover, areas of atrophy were apparent in 
the diameter of the tubules. Additionally, interstitial 
spaces were expanded with edema, and congestion and 
thromboses were present in the vessels. Hyperchromasia 
and pyknosis of the nuclei of the spermatogonia and 
vacuolization and degeneration of Sertoli and germ cells 
were also observed (Figure 1C). Alterations were also 
noted in the rat testicles in the MTX + SMN group, but 
these changes were significantly less when compared 
to those in the rats in the MTX group. Lesions were 
localized in some tubules. However, the architecture 
of the tubules remained intact. A small number of 
germinal cells were seen in the tubular lumen. The rate 
of tubular atrophy and degeneration of germinal cells 
was lower in the MTX + SMN group than the MTX 
group. Spermatogenic cells in the seminiferous tubules 
continued spermatogenesis in a manner that included 
spermatozoa, and fewer pathomorphological changes 
were seen in the spermatogonia of the MTX + SMN group 
than those of the MTX group. Leydig cells were in the 
normal histological form. The spermatids developing in 
the tubules had near-normal structure (Figure 1D).
Immunohistochemical findings
Table II summarizes the findings of the IHC 
experiments. We evaluated GPx1 immune expression 
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in the testicular tissue sections. No immune reaction 
was observed in the negative control (Figure 2A). 
GPx1 immunoreactivity was observed in the testicular 
tissue sections from all other groups. The control and 
SMN group sections had the most intense staining, 
with similar densities. Immunoreactions were observed 
in Leydig and germ cells but not Sertoli cells, and the 
immunoreactivity was more intense in the nucleus than 
the cytoplasm. Immunoreactions were not observed in 
the central vein, endothelium, or connective tissue of the 
vessels (Figure 2B). GPx1 expression was significantly 
decreased in the MTX group in comparison with the 
control group (Figure 2C). SMN treatment resulted 
increase of GPx1 expression in the MTX + SMN group 
(Figure 2D).
No immune reaction of SOD2 was observed 
in the negative control (Figure 3A), while positive 
immunoreactivity was observed in the testicular tissue 
sections from all other groups. The control and SMN groups 
showed the most intense staining. Immunoreactivity was 
observed in the cytoplasm of germ cells and spermatids 
but not in the nuclei. Immunoreactions were not observed 
in Sertoli cells, Leydig cells, the central vein, endothelium, 
or connective tissue of vessels (Figure 3B). SOD2 immune 
expression was significantly lower in the MTX group than 
in the control group (Figure 3C). Treatment with SMN 
resulted in almost normal SOD2 immunoreactivity in the 
MTX + SMN group (Figure 3D).
Biochemical findings
The activities of the CAT, GPx, and SOD enzymes 
in the tissue samples from the testes of all groups are 
shown in Table III. As shown in the table, significant 
alterations were seen. For example, the activities of CAT 
and GPx were significantly lower in the MTX group than 
those in the control group (p < 0.05). Compared to the 
MTX group, the MTX + SMN group showed significant 
improvements in the activities of these enzymes in the 
testicular tissues. 
The MDA levels in the tissue samples from the testes 
of all groups are shown in Figure 4. These levels were 
significantly higher in the MTX and MTX + SMN groups 
than in the control group (p < 0.05). However, the tissue 
MDA levels in the MTX + SMN group were significantly 
lower than those in the MTX group (p < 0.05).
TABLE I - Effects of MTX and SMN on the testis structure
Changes/lesions in testis Control MTX MTX+SMN SMN
Vacuolization in the germ and Sertoli cells
Slight
Moderate
Severe
-/8a 
- 
- 
-
8/8b 
1 
3 
4
4/8c 
2 
1 
1
-/8a 
- 
- 
-
Degeneration and necrosis
Slight
Moderate
Severe
-/8a 
- 
- 
-
8/8b 
1 
5 
2
8/8c 
4 
3 
1
-/8a 
- 
- 
-
Desquamated immature germ cells
 Slight
Moderate
Severe
1/8a 
1 
- 
-
8/8b 
1 
2 
5
5/8c 
2 
2 
1
2/8a 
2 
- 
-
Tubular atrophy 
Slight
Moderate
Severe
-/8a 
- 
- 
-
7/8b 
1 
2 
4
4/8c 
1 
2 
1
-/8a 
- 
- 
-
Intertubular edema
Slight
Moderate
Severe
-/8a 
- 
- 
-
7/8b 
1 
3 
3
3/8c 
1 
1 
1
-/8a 
- 
- 
-
The values present the number of rats showing change/number of rats examined in each treatment group. Values with different 
letters (a, b and c) in same row are significantly different (P <0.01), according to the Chi-Square test.
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Spermatological findings
As shown in Table IV, there were significant 
differences in density, motility, dead-to-live sperm ratio, 
and abnormal sperm rate between the MTX and MTX + 
SMN groups in comparison with the control group (p < 
0.05).
The present study demonstrated that SMN treatment 
effectively protected rats against MTX-induced testicular 
toxicity, as evidenced by decreased MDA levels and 
elevated antioxidant levels. These protective effects of 
SMN against MTX-induced testicular toxicity were also 
approved by histopathological, immunohistochemical, and 
spermatological investigations.
In previous studies conducted to reveal the effect 
of MTX on testicular cells, MTX was found to decrease 
antioxidant activity in the cells. This made the cells 
vulnerable to the effects of ROS, and thereby caused damage 
in testicular tissues and germ cells, atrophy in seminiferous 
tubules, and apoptosis in germ cells (Vardi et al., 2010; 
FIGURE 1 - Histopathological appearance of cross-sections of the rat testes. (A) Control and (B) SMN groups showed normal 
seminiferous tubule morphology and spermatogenic cells in advanced stages. Additionally, all germ cells were present and appeared 
normal. (C) The testes of the MTX group showed atrophy of the seminiferous tubules and arrested spermatogenesis (stars). The 
seminiferous tubules were irregular and had only Sertoli cells and spermatogonia. Vacuolization was apparent in the germ and 
Sertoli cells (arrowhead) with desquamated immature cells in the lumen of the seminiferous tubules (arrow). (D) In the testes of the 
MTX + SMN group, the morphology of the seminiferous tubules was almost normal. The spermatogenic cells in the seminiferous 
tubules (stars) continued spermatogenesis in a manner that included spermatozoa (H&E, 200x).
TABLE II - Quick scores for GPx1 and SOD2 immun expression in testis tissue of rats
Parameters Control MTX MTX+SMN SMN
GPx1 immunoreactivity of Leydig cells 4.07±0.45a 2.23±0.41b 3.34±0.45c 3.97±0.50a
GPx1 immunoreactivity of Germ cells 6.27±0.81a 3.02±0.55b 4.38±0.38c 6. 13±0.77a
SOD2 immunoreactivity of Germ cells 6.66±0.40a 3.09±0.98b 5.14±0.27c 6.30±0.44a
Values with different letters (a, b and c) in same row are significantly different (P <0.05), according to the One way ANOVA test.
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Padmanabhan et al., 2008). Ultimately, damage to the 
sperm DNA was established along with decreased testicular 
weight and sperm count, and increased abnormalities of 
the sperm head (Johnson et al., 1994). Padmanabhan et 
al. established morphological changes in seminiferous 
tubules, such as irregularities and vacuolizations, and 
decreases in spermatogonial cell series and spermatid 
counts (Padmanabhan et al., 2008). In turn, Saxena et al. 
(2004) reported an explicit decrease in the diameter of 
seminiferous tubules, sporadic thinning, irregularities in 
the basal membrane, expansion in the intertubular space, 
different sizes of primary and secondary spermatocytes and 
spermatids, and substantial decreases in the size of Sertoli 
and Leydig cells. In the current study, similar findings 
were detected in the MTX group. These changes were 
significantly reduced in the MTX + SMN treatment group. 
Results suggest that the damage in the testicles of the MTX 
group was protected with SMN in the MTX + SMN group.
In the present study, we immunohistochemically 
investigated whether the antioxidant enzymes GPx1 and 
SOD2 had a protective effect that could eliminate the free 
radicals forming with MTX. GPx1, which is one of the 
natural antioxidant defense systems against free radicals, 
protects lipid peroxidation by catalyzing the reduction of 
hydrogen peroxide (H2O2) or organic hydroperoxides to 
water or alcohols by using reduced glutathione (Herbette, 
Roeckel-Drevet, Drevet, 2007), and it protects cell 
membranes against oxidative damage (Czuczejko et al., 
2003). SOD is one of the major antioxidant enzymes that 
protects the male reproductive organs against the harmful 
effects of ROS and it plays an important role in testicular 
development and spermatogenesis (Fujii et al., 2003; 
Prahalathan, Selvakumar, Varalakshmi, 2004). SOD2 (Mn-
SOD) serves as a necessary defender against mitochondrial 
superoxide radicals (McIntyre, Bohr, Dominiczak, 2009). 
Previous studies have suggested that SOD2 has a ROS 
scavenging capacity (Nomiyama et al., 2003). Changes 
that take place in this enzyme may lead to impaired 
testicular functions and the cessation of sperm development 
(Prahalathan, Selvakumar, Varalakshmi, 2004). 
In the present study, MTX caused a lowering of 
GPx1 and SOD2 immunoreactivities in testicular tissue. 
FIGURE 2 - GPx1 immunolocalization in cross-sections of the rat testes. (A) The negative control showed no GPx1 staining. (B) 
The control group showed strong nuclear expression of GPx1 in the germ (thick arrows) and Leydig cells (thin arrow). No staining 
was observed in the Sertoli cells (arrowhead). (C) The MTX group showed weak nuclear GPx1 immunoreactivity in the germ 
(arrows) and Leydig cells (arrowhead). (D) The MTX + SMN group showed intense nuclear GPx1 immunoreactivity in the germ 
(thick arrows) and Leydig (thin arrow) cells.
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However, GPx1 and SOD2 immunoreactivities in the 
testes of rats treated with SMN increased significantly 
compared to the MTX group. Immunohistochemical 
results were consistent with the biochemical results. 
Increased activities of these enzymes are known to serve 
as protective enzymes for the elimination of reactive free 
radicals (Cheung et al., 2011)
It has been reported that MTX could cause a reduction 
in levels of GPx, SOD, and CAT in testis tissue (Vardi et al., 
2010; Yuluğ et al., 2013). In the present study, the decreased 
levels in the MTX group were compatible with the findings 
of previous studies. On the other hand, the activities of 
these enzymes in the MTX + SMN group were comparable 
with those of the control group. The observation that the 
application of SMN caused the GPx and CAT levels to 
increase to their normal levels in the MTX + SMN-treated 
group indicates that the testes were restored to their normal 
activity by the protective effect of SMN.
Malondialdehyde (MDA) is widely used as an 
indicator of lipid peroxidation (Esterbauer et al., 1982). 
Increased MDA levels might have resulted from an 
increase in ROS as a result of an oxidative stress condition 
(Yaman, Yener, Celik, 2016). Also, an increased MDA 
level is a significant indicator of oxidative membrane 
damage (Freeman, Crapo, 1981). Increased oxidative 
stress with MTX has been reported to result in the 
production of ROS, which causes oxidative damage by 
decreasing Nicotinamide adenine dinucleotide phosphate 
(NADPH) and increasing MDA (Vardi et al., 2010). In the 
present study, treatment with SMN significantly decreased 
the MDA contents in the MTX + SMN group. This result 
indicates the restorative effects of SMN on the MDA levels 
of testis tissue.
The protective effect of SMN treatment may be 
due to its protection of cellular membranes against 
oxidative damage (Nencini, Giorgi, Micheli, 2007). 
Such antioxidant effects of SMN can be explained by the 
presence of bioactive chemical components present in 
SMN, such as flavolignans, silydianin, silychristin, and 
silybin (Farghali et al., 2000).
The chemotherapeutic agent most commonly 
studied on laboratory animals in terms of the gonadal 
FIGURE 3 - SOD2 immunolocalization in cross-sections of rat testes. (A) The negative control showed no SOD2 staining. (B) 
The control group showed strong SOD2 expression in the cytoplasm of the germ (arrows) cells and spermatids (stars). No staining 
was observed in the Sertoli and Leydig cells. (C) The MTX group showed weak cytoplasmic SOD2 immunoreactivity in the germ 
cells (arrows). (D) The MTX + SMN group showed stronger cytoplasmic SOD2 immunoreactivity in the germ cells (arrows) and 
spermatids (stars) than the MTX group did.
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toxicity of anti-metabolites is MTX. Due to its damages 
to the spermatogenic cells, MTX is reported as one of the 
agents that can cause infertility (Vardi et al., 2010). The 
testicular damage related to the MTX-induced oxidative 
stress occurs directly in the spermatogenic cells and 
Sertoli cells, and leads to dysfunction of Leydig cells and 
therefore, reduced testosterone levels. It was reported that 
low and moderate doses of MTX cause oligospermia in 
rats, but do not lead to testicular atrophy (Johnson et al., 
1994). On the other hand, studies with MTX on rat testicles 
found decreases in testicular weight,  (Vardi et al., 2010), 
fatal effects on all spermatogenic cells, particularly on 
spermatocytes and spermatids and reducing effects on 
the size of Sertoli and Leydig cells (Saxena et al., 2004). 
Furthermore, the findings of cytogenetic studies on mice 
suggest that MTX leads to varying degrees of chromosomal 
aberrations, DNA damage, and apoptosis in germ cells; 
decreases in epididymal sperm count and motility, and 
increases in abnormal sperm rates (Padmanabhan et al., 
2008). In the presented study, there were significant 
differences (p<0.05) in density, motility, dead-live sperm 
rate and abnormal sperm rate in the MTX group rats 
compared to MTX + SMN and control group. It was seen 
that such effect occurred only in the MTX group due to the 
damage in the testicles, and was not observed in the MTX 
+ SMN group due to the protective effect of SMN.
CONCLUSION
We conclude that SMN appears to have a protective 
role in MTX-induced testicular toxicity as it enhances the 
activities of antioxidant enzymes, decreases MDA levels, 
and protects spermatogenesis. We think this protective effect 
of SMN may be due to its antioxidant activity. Therefore, 
FIGURE 4 - Effects of MTX and SMN on MDA levels in testis 
tissue of rats.
TABLE III - Effects of MTX and SMN on antioxidant defense systems in testis tissue of rats
Parameters
Experimental groups
Control MTX MTX+SMN SMN
CAT U/g 82.16±8.21 47.75±9.18a 63.36±5.53ab 89.18±8.79b
GPx U/g 85.32±10.02 46.52±11.42 a 59.49±8.33ab 79.74±15.12b
SOD U/g 1982.19±48.84 2047.72±62.43 1972.14±83.19 2086.16±56.83
Each value represents the Mean ± SD. a: significantly different from control group b: significantly different from MTX group at 
p < 0.05 (One way ANOVA).
TABLE IV - Effects of MTX and SMN on Spermatological data by study groups
Parameters Control MTX MTX+SMN SMN
Sperm concentration (x109/ml) 4.02 ± 0.38a 1.14±0.52b 2.92 ± 0.25c 3.93 ± 1.03a
Sperm motility (%) 78.14 ± 4.05a 8.12±4.36b 56.41 ± 2.17c 75.43 ± 4.73a
Dead live (%) 7.11 ± 2.15a 64.27±4.25b 26.45 ± 6.91c 9.15 ± 1.24a
Abnormal sperm rate (%) 10.17a 95.55b 38.65c 9.85a
Head abnormality (%) 3.03a 27.26b 17.05c 2.75a
Acrosome abnormality (%) 0.5a 8.33b 5.69c 0.5a
Mid piece abnormality (%) 2.18a 6.49b 3.75c 1.89a
Tail abnormality (%) 3.34a 12.58b 6.71c 3.28b 
Values with different letters (a, b and c) in same row are significantly different (P <0.05), according to the One way ANOVA test.
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SMN can be used in clinical practice for preventing side 
effects that can occur in testicles due to MTX use. However, 
this study needs to be supported with other experimental and 
clinical research to understand the underlying mechanisms 
responsible for changing the balance between the oxidative 
processes and antioxidant defense systems.
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